Literature DB >> 12489602

Preventing blood-borne infections through pharmacy syringe sales and safe community syringe disposal.

T Stephen Jones1, Phillip O Coffin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12489602     DOI： 10.1331/1086-5802.42.0.s6.jones

Source DB:  PubMed          Journal:  J Am Pharm Assoc (Wash)        ISSN： 1086-5802


× No keyword cloud information.
  13 in total

1.  Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003.

Authors:  Ryan J Deibert; Gary Goldbaum; Theodore R Parker; Holly Hagan; Robert Marks; Michael Hanrahan; Hanne Thiede
Journal:  Am J Public Health       Date:  2006-06-29       Impact factor: 9.308

2.  Placing the dynamics of syringe exchange programs in the United States.

Authors:  Barbara Tempalski
Journal:  Health Place       Date:  2006-06-21       Impact factor: 4.078

3.  Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.

Authors:  Barbara Tempalski; Hannah L Cooper; Samuel R Friedman; Don C Des Jarlais; Joanne Brady; Karla Gostnell
Journal:  Int J Drug Policy       Date:  2008-03-04

4.  Demographic, risk, and spatial factors associated with over-the-counter syringe purchase among injection drug users.

Authors:  Thomas J Stopka; Alexandra Lutnick; Lynn D Wenger; Kathryn Deriemer; Estella M Geraghty; Alex H Kral
Journal:  Am J Epidemiol       Date:  2012-05-04       Impact factor: 4.897

5.  Randomized, community-based pharmacy intervention to expand services beyond sale of sterile syringes to injection drug users in pharmacies in New York City.

Authors:  Natalie D Crawford; Silvia Amesty; Alexis V Rivera; Katherine Harripersaud; Alezandria Turner; Crystal M Fuller
Journal:  Am J Public Health       Date:  2013-07-18       Impact factor: 9.308

6.  Increasing safe syringe collection sites in New York State.

Authors:  Susan J Klein; Alma R Candelas; Jay G Cooper; Wesley E Badillo; James M Tesoriero; Haven B Battles; Hope A Plavin
Journal:  Public Health Rep       Date:  2008 Jul-Aug       Impact factor: 2.792

7.  Syringe acquisition experiences and attitudes among injection drug users undergoing short-term opioid detoxification in Massachusetts and Rhode Island.

Authors:  Nickolas D Zaller; Michael A Yokell; Sandeep M Nayak; Jeannia J Fu; Alexander R Bazazi; Josiah D Rich
Journal:  J Urban Health       Date:  2012-08       Impact factor: 3.671

8.  Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.

Authors:  Thomas J Stopka; Ashley Donahue; Marguerite Hutcheson; Traci C Green
Journal:  J Am Pharm Assoc (2003)       Date:  2017-02-08

9.  Factors associated with presence of pharmacies and pharmacies that sell syringes over-the-counter in Los Angeles County.

Authors:  Thomas J Stopka; Estella M Geraghty; Rahman Azari; Ellen B Gold; Kathryn Deriemer
Journal:  J Urban Health       Date:  2013-12       Impact factor: 3.671

10.  A multistate trial of pharmacy syringe purchase.

Authors:  Wilson M Compton; Joe C Horton; Linda B Cottler; Robert Booth; Carl G Leukefeld; Merrill Singer; Renee Cunningham-Williams; Wendy Reich; Karen Fortuin Corsi; Michele Staton; Joseph L Fink; Thomas J Stopka; Edward L Spitznagel
Journal:  J Urban Health       Date:  2004-12       Impact factor: 3.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.